Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Low vitamin D3 is not linked to different levels of thyroid hormones in people with autoimmune thyroid disease.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Treatments that reduce oxidative stress and fix mitochondrial problems may help heal chronic wounds.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Nanoemulsions with minoxidil and clove oil effectively target hair follicles for better alopecia treatment.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CD2 might be a new treatment target for patchy alopecia areata.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Chemokine signaling is important for hair development.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Blocking interferon-gamma might help treat various autoimmune diseases.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.